Skip to content

Antibiotic Prophylaxis in Prosthetic Breast Reconstructions

Antibiotic Prophylaxis in Prosthetic Breast Reconstructions

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02012517
Enrollment
160
Registered
2013-12-16
Start date
2014-01-31
Completion date
2017-12-31
Last updated
2013-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgical Site Infections

Keywords

surgical site infection, breast reconstruction, drains, prophylaxis

Brief summary

The added benefit of prolonged antibiotic prophylactic treatment in patients undergoing breast reconstruction who have drains placed for several days after surgery is controversial. In this study we aim to compare two prophylactic regimens: 1. 24 hour antibiotic treatment prior to surgery with cefazolin 2. a prolonged antibiotic regimen consisting of 48 hours cefazolin treatment followed by oral therapy with cephalexin until the removal of the drains. Patients will sign an informed consent form prior to the surgery and will be randomized to one of the antibiotic regimens. Patients will be closely followed up to one year after surgery. The number of surgical site infections according to the NNIS criteria and loss of breast implants will be compared between the two groups.

Interventions

DRUGProlonged antibiotic treatment
DRUGShort antibiotic course (standard of care)

Sponsors

Sheba Medical Center
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

All criteria should be present: 1. Signing an informed consent form 2. Reconstructive breast surgery 3. One drain or more remained after surgery -

Exclusion criteria

Age \< 18 years Active infection at the surgical site at the operation time or in close proximity to the surgical site Immune deficiency state \-

Design outcomes

Primary

MeasureTime frameDescription
surgical site infection1 yearThe percentage and number of surgical site infections assessed according to the NNIS criteria up to one year after reconstructive breast surgery will be compared between the two groups

Countries

Israel

Contacts

Primary ContactYasmin Maor, MD
yasmin.maor@sheba.health.gov.il

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026